Preview

Tanzania’s Leading German Pharmaceutical Companies Profiles & Details, Q3 2014

Good Essays
Open Document
Open Document
423 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Tanzania’s Leading German Pharmaceutical Companies Profiles & Details, Q3 2014
Researcher’s View: Sourcing accurate and reliable quantitative data on Tanzania’s pharmaceutical market remains challenging due to substandard audits, porous sales channels, a high prevalence of counterfeits, questionable national statistics, dispensing without prescriptions, sizeable ‘grey markets’ and the widespread use of traditional remedies. Researcher takes into account the import dependence of countries for medicines and assumes that economic growth as well as the resulting increase in the size of Tanzania’s middle-class population will lead to an increase in demand for medicines. Moreover, the country’s rising population and increasing urbanization will increase spending on medicines over the forecast period.

Nevertheless, due to currently low purchasing power, generic drugs comprise the majority of Tanzania’s pharmaceuticals market. We also do not expect Tanzania’s reliance on imported drugs to decrease in the short term, even though the government has been encouraging the production of drugs locally.

Headline Expenditure Projections
Pharmaceuticals: TZS693.94bn (USD429mn) in 2013 to an expected TZS806.32bn (USD498mn) in 2014; +16.2% growth in local currency terms and +16.1% in US dollar terms.

Healthcare: TZS 4,120bn (USD2.55bn) in 2013 to TZ 5,130bn (USD3.17bn) in 2014; 24.5% growth in local currency terms and 24.4% in US dollar terms.
Inquire before Buying @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=13784 .
Table Of Contents

Researcher Industry View 7
SWOT 10
Political 11
Economic 12
Business Environment 14
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Tanzania 2010-2018) 17
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2010-2018) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Tanzania 2010-2018) 20
Table: Private Healthcare

You May Also Find These Documents Helpful

  • Good Essays

    The contribution made by the industry towards the GDP of the country is $ 1.2 trillion, which is 8.5% of the GDP (PWC, 2011). Increase in the wholesale prices of drugs during global financial crises has increased the expenditure to $ 10 billion, which increased to $ 300 billion in the year 2009. It has also increased the inflation rate in the country. In addition to this, it also has a negative impact on the Consumer Price Index, which fell to 1.3% in the year 2009 (Wilson, 2009). It is estimated that the retail drug industry would reach US$ 1420 billion in the year 2017 and there would be a compounded annual growth rate of 3.6% in the next 5 years (Reuters, 2012).…

    • 1293 Words
    • 6 Pages
    Good Essays
  • Good Essays

    Enabling mighty competition between commonplace drug treatments and patent-expired fashioned brands is relevant to decreasing pharmaceutical charges and stimulating innovation. However, this mentioned, there are numerous troubling problems surrounding general medicines because of the convenient access to an abundance of illegal generics on the internet breaking the patent ownership and the unregulated companies that produce and supply them. At the same time familiar medicines will have to be approved identical types of depended on drugs, providing the equal fine, safety and efficacy because the normal, that is commonly no longer the case. A conventional drug must endure strict scrutiny before it is licensed and given market approval with the aid of countrywide medicines authorities. In brief, common medicines will have to comply with the same strict standards of great, safety and efficacy as usual pharmaceutical…

    • 490 Words
    • 2 Pages
    Good Essays
  • Best Essays

    Gilead Science Case

    • 3088 Words
    • 13 Pages

    The company’s managers have also been successful in obtaining approvals for the company’s new Harvoni drug in the US in 2014, and in the UK in 2015, and still awaits the highly likely approval of the drug from the EU. All of which will likely boost the company’s sales during 2015 to exceed the current $12.1 Billion figure.…

    • 3088 Words
    • 13 Pages
    Best Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Satisfactory Essays

    Final Paper Outline

    • 477 Words
    • 2 Pages

    My final paper will focus in the Peruvian generic medicine market. The Peruvian market is dominated by the leading laboratories who set the prices and control the brands. Peruvian customers are used to follow doctors prescriptions strictly and believe that the use of generics is dangerous. This situation allows the laboratories to capture the market and set the prices (Peruvian medicines are more expensive than in the USA). The Peruvian health agency; "Ministerio de salud" signed a cooperation agreement with national association of pharmacies for them to distribute 83 of the most used generic medicines along with the brand medicines. They never kept up the agreement, and the pharmacies refuse to sell generic medicines.…

    • 477 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    An issue with the distribution of drugs is that it is more profitable for drug companies to sell the drugs in MEDC’s than LEDC’s. An example of this would be GlaxoSmithKline, as they mainly sell their products in MEDC’s, but in many cases, the countries with…

    • 381 Words
    • 2 Pages
    Good Essays
  • Good Essays

    Prescription drugs are drugs that save millions of people's lives everyday. Many people depend on these things in order to keep them alive. Although, major pharmaceuticals companies view this as a very dependable way of receiving capital, having to need these things in order to live another day. Since people most of time need this drug in order to survive they are willing to pay thousands of dollars just so they could live another day. There are many people who require these specific things in order to survive. When it comes corrupt CEO’s, companies, and statistics the prescription drug business is going down hill.…

    • 516 Words
    • 3 Pages
    Good Essays
  • Good Essays

    A problem that affects more than 70% percent of Americans and costs those same Americans over $250 billion annually (Sparks 1). This controversial problem can only be described as the cost of prescription medication. Currently, Americans pay on average $858 annually for prescription medication which is more than 17% percent of total healthcare expenses (Thompson 1). That figure is more than double the average prescription cost across 19 other industrialized countries (Thompson 1). These alarming numbers will also not stop growing, “four of the top ten prescription drugs in the United States have increased in price be more than 100 percent since 2011” (“THE FACTS ABOUT RISING PRESCRIPTION” 2 ). An antimalarial drug was just increased by more than 5,000% from about $13 to $750 (Thompson 2). These rising prices caused more than 35 million Americans to not fill their prescriptions last year (Sanders 1).…

    • 1294 Words
    • 6 Pages
    Good Essays
  • Best Essays

    Cited: Angell, Marcia. "Excess in the Pharmaceutical Industry." CMAJ : Canadian Medical Association journal = journal de l 'Association medicale canadienne 171.12 (2004): 1451-3. Web.…

    • 4286 Words
    • 18 Pages
    Best Essays
  • Better Essays

    a holistic view of the prevailing policy framework covering generic drugs globally, making it possible…

    • 1161 Words
    • 5 Pages
    Better Essays
  • Good Essays

    Prescription Drugs

    • 883 Words
    • 4 Pages

    These use and application of these findings may contribute to formulation of policies by the government agencies to control the rising drug prices. Here are some of the recommendations to dealing with the current problem of high prices of prescription drugs. The government should allow for importation of drugs to put the monopolies in check. The Food and Drugs Administration should left to import prescription drugs from countries like Canada where the prices are low and her drug industry is comparable to that of the…

    • 883 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Health Care Spending

    • 2181 Words
    • 9 Pages

    Today, health care costs are rising significantly faster than the national income. Kellerman (2012) states, “The U.S. spends far more on health care per capita and as a percentage of GDP than any other nation on earth, according to the Organization for Economic Cooperation and Development” (para. 3). Furthermore, health care spending has become a paramount issue that is overshadowing other important affairs, such as education. The level of current national health expenditures, why spending is too much, evaluation of where the nation should cut or add spending, examination of financing of health care, and a forecast of future economic needs of the health care system will be explored.…

    • 2181 Words
    • 9 Pages
    Powerful Essays
  • Better Essays

    Healthcare Spending

    • 1728 Words
    • 7 Pages

    National health care spending within the United States is at an all-time high and continues to rise. The nation is driving into economic woes with health care at helm. This paper will provide an overview of current national health care expenditures. It will also provide opinions on if the spending is sufficient and where and why cuts should be made. To help understand costs and payment, a breakdown of how health care is financed is included. The second half of the paper will provide a forecast of the future economic needs of U.S. health care, why these needs must be addressed, and my opinion on how the finances will be covered.…

    • 1728 Words
    • 7 Pages
    Better Essays
  • Powerful Essays

    In the past several years some critical changes have been taking place in the pharmaceutical industry which included encouragement of generic prescriptions by the formularies, the exclusive listing of a single drug for a particular therapeutic prescription, enablement of bulk discount rate negotiation by health care insurers, and the minimization of the number of drugs to be put in the formularies. These changes pressured the pharmaceutical manufacturers to reduce the…

    • 1583 Words
    • 7 Pages
    Powerful Essays
  • Powerful Essays

    Sanofi-Aventis Acquisition

    • 5913 Words
    • 19 Pages

    Particularly, the worldwide sales in pharmaceutical products reached the $550 billion in 2004 and $466 billion in 2003, which implied a growth of 7% and 9% over the previous year. These sales were concentrated in USA, where the market share was about 45% of the global sales. 40% of the total industry revenues took place in Europe and Japan.…

    • 5913 Words
    • 19 Pages
    Powerful Essays